期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Benefit of stem cells and skeletal myoblast cells in dilated cardiomyopathies 被引量:4
1
作者 Luiz César Guarita-Souza Júlio César Francisco +2 位作者 Rossana Simeoni Jose Rocha Faria-Neto Katherine Athayde Teixeira de Carvalho 《World Journal of Cardiology》 CAS 2011年第3期93-97,共5页
Although some authors suggest that there is mitotic division in the heart,most cardiomyocytes do not have the capacity to regenerate after myocardial infarction and when this occurs there is a deterioration of contrac... Although some authors suggest that there is mitotic division in the heart,most cardiomyocytes do not have the capacity to regenerate after myocardial infarction and when this occurs there is a deterioration of contractile function,and if the area of infarction is extensive ventricular remodeling may occur,leading to the development of heart failure.Cell transplantation into the myocardium with the goal of recovery of cardiac function has been extensively studied in recent years. The effects of cell therapy are based directly on the cell type used and the type of cardiac pathology.For myocardial ischemia in the hibernating myocardium, bone marrow cells have functional benefits,however these results in transmural fibrosis are not evident. In these cases there is a benefit of implantation with skeletal myoblasts,for treating the underlying cause of disease,the loss of cell contractility. 展开更多
关键词 Cell transplantation CARDIOMYOPATHY SKELETAL MYOBLASTS Stem CELLS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部